S&P 500 7,500.24 -0.12% NASDAQ 25,719.07 -0.46% DOW 52,212.32 -0.02% R2K 2,957.13 -1.01% VIX 16.90 -0.88% US 10Y 4.66 +0.63% DXY 101.13 -0.05% GOLD 4,138.40 +1.65% CRUDE 86.92 +2.37% BITCOIN 65,899.42 -0.91%
Next Bullish Trade
Sign in
SLGL

Sol-Gel Technologies Ltd. SLGL

$84.41 -5.33 (-5.94%)
Extended · +1.10σ
Mkt cap $0.3B
P/E
Day $84.41 – $93.74
52wk $48.26 – $97.97
Avg vol
Beta
Div yld
Next earnings

Quick read

At a glance

Sol-Gel Technologies Ltd. is a healthcare company listed in the US.

SLGL last traded at $84.41, down 5.9% on the day; that's in the upper part of its 52-week range ($48.26–$97.97). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.

A quick snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →
21 EMA +1 ATR +2 ATR −2 ATR
O H L C

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $16.63 (fair range $2–$18); today's price sits 370% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Adequate. Model estimates only — do your own due diligence.

Overvalued -370% margin of safety Accounting: Adequate
Intrinsic (DCF)
$16.63
Fair-value range
$1.69 – $17.92
Margin of safety
-370%
Accounting quality Adequate
  • ✓ More cash than debt
  • ✓ Quick ratio 8.88 (antifragile)
  • ✓ Current ratio 4.37 (antifragile)
  • ✓ Debt/equity 0.31 (antifragile)
  • ⚠ Negative retained earnings

Price implies ~77% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

SLGL is a $251 million company.

Market cap $0.3B
P/E ttm
Beta
52w range $48.26 – $97.97
Avg volume
Dividend yield
Sector Healthcare
Next earnings
52-week range · today's price
$48.26$97.97

More on SLGL